Company description

Surdex Corporation (SRDX) is a leading medical technology company founded in 1970 and headquartered in Cambridge, Massachusetts. The company specializes in developing and commercializing innovative pharmaceutical and medical device products for a variety of therapeutic areas, including ophthalmology and neurology. Surdex's mission is to improve patients' lives by providing high-quality, accessible and affordable healthcare solutions. With over 50 years of experience, Surdex has established itself as a trusted and reliable partner in the healthcare industry. The company's portfolio includes a wide range of FDA-approved products, such as diagnostic tests, ophthalmic surgical devices, and pharmaceuticals. Surdex's cutting-edge research and development capabilities have resulted in numerous patents and industry awards, solidifying its position as a leader in the field. Surdex's commitment to innovation and patient care is reflected in its partnerships with healthcare organizations and institutions worldwide. The company has a strong global presence, with operations in North America, Europe, and Asia, and distributes its products to over 70 countries. Furthermore, Surdex has a dedicated team of over 1,500 employees who are passionate about driving the company's growth and fulfilling its vision of being a global leader in medical technology. As a socially responsible company, Surdex prioritizes sustainability and ethical business practices. The company has implemented various initiatives to reduce its environmental impact and support the communities in which it operates. Surdex also maintains a strong corporate governance framework, ensuring transparency and accountability in all its operations